Cyted is focused on providing digital diagnostic infrastructure to revolutionise the early detection of cancer. Their technology uses artificial intelligence and novel biomarkers to aid the understanding of clinicians and improve patient outcomes.
Location: United Kingdom, England, Cambridge
Member count: 51-200
Total raised: $624.732K
Founded date: 2020
Investors 1
| Date | Name | Website |
| 19.05.2023 | BGF Ventur... | bgf.co.uk |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 03.05.2022 | - | $624.732K | - | - |
Mentions in press and media 8
| Date | Title | Description | Category | Author | Source |
| 19.05.2023 | Cambridge-... | Cambridge-based Cyted, an earl... | funding m... | Vignesh R. | siliconcan... |
| 04.02.2022 | Annual #21... | Next month’s coveted #21toWatc... | - | - | cambridgen... |
| 04.02.2022 | Annual #21... | Annual #21toWatch announces sh... | - | - | cambridgen... |
| 09.06.2021 | Cambridge ... | Cambridge GPs host UK’s first ... | - | - | cambridgen... |
| 19.04.2021 | AI could e... | AI could ease pressures on dia... | - | - | cambridgen... |
| 19.10.2020 | Cyted acqu... | Cyted acquires Pathognomics Lt... | - | - | cambridgen... |
| 30.09.2020 | Cyted appo... | Cyted appoints Martin Frost as... | - | - | cambridgen... |
| - | Cyted | “Our unique approach combines ... | - | - | fastfounde... |